Angiotensin II
血管紧张素II
Report date: 2026/05/14 20:00:28
NMEFirst In Class
Base Information
Drug NameAngiotensin II
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[17]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2017/12/21
Country/Territory +[14]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesLa Jolla Pharma
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of California San FranciscoInnoviva Specialty Therapeutics IncThe Brigham and Women's Hospital +[11]
Inactive CompaniesVanderbilt University Medical CenterGeorge Washington University (The)University Of California, Los Angeles
Active Indications +[13]
Inactive Indications +[4]